1-6 of 6
Robert F Coniff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients

Peter S Johnston, MD, Peter U Feig, MD, Robert F Coniff, MD, Alice Krol, MS, Jaime A Davidson, MD, Steven M Haffner, MD
Journal: Diabetes Care
Diabetes Care 1998;21(3):409–415
https://doi.org/10.2337/diacare.21.3.409
Published: 01 March 1998
View article titled, Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients
Open the PDF for Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients in another window
Journal Articles

Chronic Treatment of African-American Type 2 Diabetic Patients With β-Glucosidase Inhibition

Peter S Johnston, MD, Peter U Feig, MD, Robert F Coniff, MD, Alice Krol, MS, David E Kelley, MD, Arshag D Mooradian, MD
Journal: Diabetes Care
Diabetes Care 1998;21(3):416–422
https://doi.org/10.2337/diacare.21.3.416
Published: 01 March 1998
View article titled, Chronic Treatment of African-American Type 2 Diabetic Patients With β-Glucosidase Inhibition
Open the PDF for Chronic Treatment of African-American Type 2 Diabetic Patients With β-Glucosidase Inhibition in another window
Journal Articles

Acarbose in the Treatment of Type I Diabetes

Priscilla Hollander, MD, PHD, Xavier Pi-Sunyer, MD, Robert F Coniff, MD
Journal: Diabetes Care
Diabetes Care 1997;20(3):248–253
https://doi.org/10.2337/diacare.20.3.248
Published: 01 March 1997
View article titled, Acarbose in the Treatment of Type I Diabetes
Open the PDF for Acarbose in the Treatment of Type I Diabetes in another window
Journal Articles

A Double-Blind Placebo-Controlled Trial Evaluating the Safety and Efficacy of Acarbose for the Treatment of Patients With Insulin-Requiring Type II Diabetes

Robert F Coniff, MD, Jo Ann Shapiro, MS, Timothy B Seaton, MD, Byron J Hoogwerf, MD, John A Hunt, MD
Journal: Diabetes Care
Diabetes Care 1995;18(7):928–932
https://doi.org/10.2337/diacare.18.7.928
Published: 01 July 1995
View article titled, A Double-Blind Placebo-Controlled Trial Evaluating the Safety and Efficacy of Acarbose for the Treatment of Patients With Insulin-Requiring Type II Diabetes
Open the PDF for A Double-Blind Placebo-Controlled Trial Evaluating the Safety and Efficacy of Acarbose for the Treatment of Patients With Insulin-Requiring Type II Diabetes in another window
Journal Articles

Reduction of Glycosylated Hemoglobin and Postprandial Hyperglycemia by Acarbose in Patients With NIDDM: A placebo-controlled dose-comparison study

Robert F Coniff, MD, Joann A Shapiro, MS, David Robbins, MD, Robert Kleinfield, PHD, Timothy B Seaton, MD, Paul Beisswenger, MD, Janet B McGill, MD
Journal: Diabetes Care
Diabetes Care 1995;18(6):817–824
https://doi.org/10.2337/diacare.18.6.817
Published: 01 June 1995
View article titled, Reduction of Glycosylated Hemoglobin and Postprandial Hyperglycemia by Acarbose in Patients With NIDDM: A placebo-controlled dose-comparison study
Open the PDF for Reduction of Glycosylated Hemoglobin and Postprandial Hyperglycemia by Acarbose in Patients With NIDDM: A placebo-controlled dose-comparison study in another window
Journal Articles

Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients

Peter S Johnston, MD, Robert F Coniff, MD, Byron J Hoogwerf, MD, Julio V Santiago, MD, F Xavier Pi-Sunyer, MD, Alice Krol
Journal: Diabetes Care
Diabetes Care 1994;17(1):20–29
https://doi.org/10.2337/diacare.17.1.20
Published: 01 January 1994
View article titled, Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients
Open the PDF for Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients in another window